We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The prospect of an actively personalized approach to the treatment of glioblastoma has moved a step closer with the recent publication in Nature of favorable data from the phase 1 study GAPVAC-101, testing a novel therapeutic concept tailored to specific
The liver cancer drug market size is expected to grow from USD870 million (2017) to nearly USD4 billion (2027), which will benefit from the marketing of other 8 high-priced biologics and the extensive promotion of nivolumab as a first-line therapy.
Liver cancer has become one of the tumors with high fatality rate among cancers in the U.S., and is mainly treated through systemic palliative care in the advanced stage.
Zika virus (ZIKV) spread rapidly worldwide since its outbreak in May 2015 and was listed as a “public health emergency of international concern” by WHO.